Clinical Trials Of Trials Planned To Initiate And Estimated

By Author: khansurry
Total Articles: 37
Comment this article

The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data included planned clinical trials with a start date from January 1 to December 31, 2022, captured in the database as of December 20, 2021. The planned trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials. Clinical trials with an ongoing or planned status with an end date between January 1 and December 31, 2022, were also examined. The trials that are estimated to be completed in 2022 were split by phase, status, indication, sponsor type, top sponsors, and geography. Additional analyses were completed for COVID-19 trials planned to be initiated or expected to be completed in 2022. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.

Click for Detail report:
https://bit.ly/3Qo82Aa